Table 1.
Patient Demographic and Clinical Characteristics (N = 87)
| Characteristic | No. | % |
|---|---|---|
| Sex | ||
| Male | 46 | 52.9 |
| Female | 41 | 47.1 |
| Tumor location | ||
| Infratentorial | 65 | 74.7 |
| Supratentorial | 22 | 25.3 |
| Hydrocephalus | ||
| No | 32 | 36.8 |
| Yes | 55 | 63.2 |
| CSF shunting | ||
| No | 60 | 69.0 |
| Yes | 27 | 31.0 |
| Pre-CRT chemotherapy | ||
| No | 69 | 79.3 |
| Yes | 18 | 20.7 |
| Extent of resection | ||
| Gross total | 71 | 81.6 |
| Near total | 9 | 10.3 |
| Subtotal | 7 | 8.1 |
| No. of pre-CRT surgeries | ||
| 1 | 55 | 63.2 |
| 2-4 | 32 | 36.8 |
| Mean age at CRT, years | 5.99 | |
| SD | 4.46 | |
| Range | 1.06-18.87 | |
| Mean time from diagnosis to CRT, months | 5.76 | |
| SD | 11.76 | |
| Range | 0.59-69.68 | |
| Mean growth hormone at CRT,* ng/dL | 21.54 | |
| SD | 19.48 | |
| Range | 2.00-120.00 | |
Abbreviations: CRT, conformal radiation therapy; Gross-total resection, a resection after which the only remaining tumor cells were visible with the use of the operating microscope; Near-total resection, a resection after which only residual tumor < 5 mm thick was visible on postoperative neuroimaging; Subtotal resection, a resection after which > 5 mm thick of residual tumor was visible on postoperative neuroimaging; SD, standard deviation.
*
Sixty-five of 87 had growth hormone measurements.